Osteonecrosis in Gaucher disease in the era of multiple therapies: Biomarker set for risk stratification from a tertiary referral center

Background: A salutary effect of treatments for Gaucher disease (GD) has been a reduction in the incidence of avascular osteonecrosis (AVN). However, there are reports of AVN in patients receiving enzyme replacement therapy (ERT) , and it is not known whether it is related to individual treatments,...

Full description

Bibliographic Details

Published in:	eLife
Main Authors:	Mohsen Basiri, Mohammad E Ghaffari, Jiapeng Ruan, Vagishwari Murugesan, Nathaniel Kleytman, Glenn Belinsky, Amir Akhavan, Andrew Lischuk, Lilu Guo, Katherine Klinger, Pramod K Mistry
Format:	Article
Language:	English
Published:	eLife Sciences Publications Ltd 2023-05-01
Subjects:	Gaucher disease avascular osteonecrosis lysosomal disease GBA1 glucosylsphingosine
Online Access:	https://elifesciences.org/articles/87537